The metabolic investigation of sudden infant death

Annals of Clinical Biochemistry

Volumn 41, Issue 4, 2004, Pages 282-293

  Olpin, Simon E ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; CARBOXYLIC ACID; FATTY ACID; FRUCTOSE; GALACTOSE; GLUTARYL COENZYME A DEHYDROGENASE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; STEROL; VERY LONG CHAIN FATTY ACID;

ACID BASE BALANCE; ACIDURIA; AUTOPSY; BILE; BLOOD ANALYSIS; CAUSE OF DEATH; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME DEFICIENCY; FATTY ACID OXIDATION; FIBROBLAST; FRUCTOSE METABOLISM; GENETIC COUNSELING; GLYCOGEN STORAGE DISEASE; HEART DISEASE; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HYPOGLYCEMIA; INBORN ERROR OF METABOLISM; KIDNEY BIOPSY; LIVER BIOPSY; LIVER DISEASE; MENKES SYNDROME; METABOLIC ACIDOSIS; METABOLIC DISORDER; MUSCLE BIOPSY; NEWBORN SCREENING; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SUDDEN INFANT DEATH SYNDROME; TERATOLOGY; TISSUE CULTURE; UREA CYCLE; VITREOUS BODY;

AUTOPSY; BLOOD CHEMICAL ANALYSIS; CELLS, CULTURED; CHEMISTRY, ANALYTICAL; FIBROBLASTS; HUMANS; INFANT; INFANT, NEWBORN; METABOLISM, INBORN ERRORS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUDDEN INFANT DEATH;

EID: 3242725900     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563041201473     Document Type: Review

References (53)

1. Garrod AE. Inborn Errors of Metabolism. Oxford: Oxford University Press, 1909
2. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for acylcarnitines in dried post mortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47: 1166-82
3. Bennett MJ, Rinaldo P. The metabolic autopsy comes of age. Clin Chem 2001; 47: 1145-6
4. Honour JW. Benchtop mass spectrometry in clinical biochemistry. Ann Clin Biochem 2003; 40: 628-38
5. Chace DH. Mass spectrometry in the clinical laboratory. Chem Rev 2001; 101: 445-77
6. Leonard JV, Morris AAM. Inborn errors of metabolism around the time of birth. Lancet 2000; 356: 583-7
7. Beckwith JB. Observations on the pathological anatomy of the sudden infant death syndrome. In: Bergman AB, Beckwith JB, Ray CG, eds. Sudden Infant Death Syndrome. Seattle: University of Washington Press, 1970: 83-102
8. Hunt CE. Sudden infant death syndrome and other causes of infant mortality. Am J Respir Crit Care Med 2001; 164: 346-57
9. Platt MW, Blair PS, Fleming PJ, Smith IJ, Cole TJ, Leach CE, et al. The CESDI SUDI Research Group. A clinical comparison of SIDS and unexplained sudden infant deaths: how healthy and how normal? Arch Dis Child 2000; 82: 98-106
10. Cote A, Russo P, Michaud J. Sudden unexplained deaths in infancy: what are the causes? J Pediatr 1999; 135: 437-43
11. Sinclair-Smith C, Dinsdale F, Emery J. Evidence of duration and type of illness in children found unexpectedly dead. Arch Dis Child 1976; 51: 424-8
12. Saudubray J-M, Charpentier C. Clinical phenotypes: diagnosis/algorithms. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, 8th edn. New York: McGraw-Hill, 2000: 1327-403
13. Nassogne M-C, Sharrard M, Hertz-Pannier L, Armengaud D, Touati G, Delonlay-Debeney P, et al. Massive subdural haematomas in Menkes disease mimicking shaken baby syndrome. Childs Nerv Syst 2002; 18: 729-31
14. Paterson CR, Burns J, McAllion SJ. Osteogenesis imperfecta: the distinction from child abuse and the recognition of a variant form. Am J Med Genet 1993; 45: 187-92
15. Marlowe A, Pepin MG, Byers PH. Testing for osteogenesis imperfecta in cases of non-accidental injury. J Med Genet 2002; 39: 382-6
16. Bolton-Maggs PH, Hill FG. The rarer coagulation disorders: a review. Blood Rev 1995; 9: 65-76
17. Hoffman GF, Athanassopoulos S, Burlina AB, Duran M, deKlerk JB, Lehnert W, et al. Clinical course early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 1996; 27: 115-23
18. Wilkins B. Head injury: abuse or accident? Arch Dis Child 1997; 76: 393-7
19. Hartley LM, Khwaja OS, Verity CM. Glutaric aciduria type I and non-accidental head injury. Pediatrics 2001; 107: 174-5
20. Howat AJ, Bennett MJ, Variend S, Shaw L, Engel PC. Defects in the metabolism of fatty acids in sudden infant death syndrome. BMJ 1985; 290: 1771-3
21. Rinaldo P, Yoon HR, Yu C, Raymond K, Tiozzo C, Giordano G. Sudden and unexpected neonatal death: protocol for the post mortem diagnosis of fatty acid oxidation disorders. Semin Perinatol 1999; 23: 204-10
22. Arens R, Gozel D, Jain K, Muscati S, Heuser ET, Williams JC, et al. Prevalence of medium-chain dehydrogenase deficiency in sudden infant death syndrome. J Pediatr 1993; 122: 715-8
23. Boles RG, Buck EA, Blitzer MG, Platt MS, Cowan TM, Martin SK, et al. Retrospective biochemical screening of fatty acid oxidation disorders in post-mortem livers of 418 cases of sudden death in the first year of life. J Pediatr 1998; 132: 924-33
24. Kolvraa S, Gregersen N, Christiensen E, Hobolth N. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence of a defect in general acyl-CoA dehydrogenase. Clin Chim Acta 1982; 126: 53-67
25. 14C] octanoate oxidation and medium chain acyl-CoA dehydrogenase deficiency in fibroblasts. Science 1983; 221: 73-5
26. Lafolla AK, Thompson RJ Jr, Roe CR. Medium-chain acyl-CoA dehydrogenase deficiency: clinical course in 120 affected children. J Pediatr 1994; 124: 409-15
27. Andresen BS, Bross P, Udvari S, Kirk J, Gray RGF, Kmock S, et al. The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there a correlation between genotype and phenotype? Hum Mol Genet 1997; 6: 695-707
28. Wang SS, Fernhoff PM, Hannon WH, Khoury MJ. Medium chain acyl-CoA dehydrogenase deficiency human genome epidemiology review. Genet Med 1999; 1: 332-9
29. Heales SJR, Thompson GN, Massoud AF, Rahman S, Halliday D, Leonard JV. Production and disposal of medium-chain fatty acids in children with medium-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 1994; 17: 74-80
30. Fletcher JM, Pitt JJ. Fasting medium chain acyl-CoA dehydrogenase- deficient children can make ketones. Metabolism 2001; 50: 161-5
31. Bennett MJ, Allison FA, Pollitt RJ, Variend S. Fatty acid oxidation defects as a cause of sudden death in infancy. Prog Clin Biol Res 1990; 321: 349-64
32. Patterson AL, Henderson MJ, Kumar R. Metabolic autopsy: lessons from an MCAD diagnosis. In: Martin SM, ed. Proceedings of the ACB National Meeting 2003; p. 70: abstract 59
33. Brackett JC, Sims HF, Steiner RD, Nunge M, Zimmerman EM, deMartinville B, et al. A novel mutation in medium chain acyl-CoA dehydrogenase causes sudden neonatal death. J Clin Invest 1994; 94: 1477-83
34. Ruitenbeek W, Poelis PJ, Turnbull DM, Garavaglia B, Chalmers RA, Taylor RW, et al. Rhabdomyolysis and acute encephalopathy in late onset medium chain acyl-CoA dehydrogenase deficiency. J Neurol Neurosurg Psychiatry 1995; 58: 209-14
35. Rinaldo P, Raymond K, Barnes CA. Medium chain acyl-CoA dehydrogenase deficiency: sudden and unexpected death of a 45 year old woman. J Inherit Metab Dis 1999; 22: 104
36. Gregerson N, Blakemore A, Winter V, Andresen BS, Kolvraa S, Bolund L, et al. Specific diagnosis of medium chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point mutation (G985) in the MCAD gene. Clin Chim Acta 1991; 203: 23-34
37. Bennett MJ, Rinaldo P, Strauss AW. Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 2000; 37: 1-44
38. Saudubray JM, Martin D, de Lonlay P, Touati G, Poggi-Travert F, Bonnet D, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis 1999; 22: 448-502
39. Pollitt RJ, Olpin SE, Bonham JR, Cahalane SF, Naughten E. Late-presenting carnitine transport defect. Enzyme Protein 1993; 47: 175
40. Maestri NE, Clissold DB, Brusilow S. Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis. J Pediatr 1999; 134: 268-72
41. Hudak ML, Jones MD, Brusilow SW. Differentiation of transient hyperammonaemia of the newborn and urea cycle enzyme defects by clinical presentation. J Pediatr 1985; 107: 712-9
42. Munnich A, Rotig A, Cormier-Daire V, Rustin P. Clinical presentation of respiratory chain deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease, 8th edn. New York: McGraw-Hill, 2000: 2261-74
43. Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionisation-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003; 111: 1399-406
44. Leiden JM. The genetics of dilated cardiomyopathy: emerging clues to the puzzle. N Engl J Med 1997; 337: 1080-1
45. Rustin P, Chretien D, Bourgeron T, Gerard B, Rotig A, Saudubray JM, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228: 35-51
46. Robinson BH, Ward J, Goodyer P, Baudet A. Respiratory chain defects in the mitochondria of cultured fibroblasts from three patients with lacticacidaemia. J Clin Invest 1986; 77: 1422-7
47. Robinson BH, Glerum DM, Chow W, Petrova-Benedict R, Lightowlers R, Capaldi R. The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lactic acidaemia. Pediatr Res 1990; 28: 549-55
48. Robinson BH, De Meirlier L, Glerum P, Sherwood G, Becker L. Clinical presentation of mitochondrial respiratory chain defects in NADH-coenzyme Q reductase and cytochrome oxidase. Clues to pathogenesis of Leigh disease. J Pediatr 1987; 110: 216-22
49. Savasta S, Comi GP, Perini MP, Lupi A, Strazzer S, Rognoni F, et al. Leigh disease: clinical, neuroradiological, and biochemical study of three new cases with cytochrome c oxidase deficiency. J Clin Neurol 2001; 16: 608-13
50. Roe CR, Roe DS. Recent developments in the investigation of inherited metabolic disorders using cultured human cells. Mol Genet Metab 1999; 68: 243-57
51. 3H]Oleic acid: for the improved detection of long chain fatty acid oxidation defects in intact cells. J Inherit Metab Dis 1997; 20: 415-9
52. Nada MA, Rhead WJ, Sprecher H, Schulz H, Roe CR. Evidence for intermediate channeling in mitochondrial beta-oxidation. J Biol Chem 1995; 270: 530-5
53. Ile gene. Hum Mol Genet 1998; 7: 347-54